Table I Index
Table of Contents

Table I - 21
Fayette
Incidence Rate1 by Primary Site and Sex: Cases Diagnosed in 1996, Indiana

Primary Site

Total

Males Females
Number Rate Number Rate Number Rate
All sites 120 363.8 64 432.6 56 319.1
Oral cavity and pharynx * # * # * #
Lip * # * # * #
Tongue * # * # * #
Major salivary glands * # * # * #
Floor of mouth * # * # * #
Gum and other mouth * # * # * #
Nasopharynx * # * # * #
Tonsil * # * # * #
Oropharynx * # * # * #
Hypopharynx * # * # * #
Pharynx and other oral cavity * # * # * #
Digestive system 21 58.1 10 64.3** 11 52.8**
Esophagus * # * # * #
Stomach * # * # * #
Small intestine * # * # * #
Colon excluding rectum 12 32.9** * # 8 37.5**
Rectum and rectosigmoid * # * # * #
Anus, anal canal, and anorectum * # * # * #
Liver and intrahepatic bile duct * # * # * #
Gallbladder * # * # * #
Other biliary * # * # * #
Pancreas * # * # * #
Retroperitoneum * # * # * #
Peritoneum * # * # * #
Other digestive organs * # * # * #
Respiratory system 28 86.1 20 138.6 8 43.9**
Nasal cavity, ear, and sinuses * # * # * #
Larynx * # * # * #
Lung and bronchus 25 77.5 17 117.9** 8 43.9**
Trachea, pleura, and other respiratory organs * # * # * #
Bones and joints * # * # * #
Soft tissue (including heart) * # * # * #
Skin (excluding basal and squamous) 5 14.1** * # * #
Melanoma of the skin * # * # * #
Other non-epithelial skin cancers * # * # * #
Breast 13 39.1** * # 13 70.5**
Female genital system 9 29.6** -- -- 9 54.8**
Cervix uteri * # -- -- * #
Corpus uteri * # -- -- * #
Uterus, NOS * # -- -- * #
Ovary * # -- -- * #
Vagina * # -- -- * #
Vulva * # -- -- * #
Other female genital organs * # -- -- * #
Male genital system 16 44.9** 16 104.9** -- --
Prostate gland 15 40.5** 15 96.3** -- --
Testis * # * # -- --
Penis * # * # -- --
Other male genital organs * # * # -- --
Urinary system 7 22.3** 6 41.7** * #
Urinary bladder * # * # * #
Kidney and renal pelvis * # * # * #
Ureter * # * # * #
Other urinary organs * # * # * #
Eye and orbit * # * # * #
Brain and other nervous system * # * # * #
Brain * # * # * #
Other nervous system * # * # * #
Endocrine system * # * # * #
Thyroid gland * # * # * #
Other endocrine (including thymus) * # * # * #
Lymphoma 5 17.9** * # * #
Hodgkin’s disease * # * # * #
Non-Hodgkin’s lymphoma 5 17.9** * # * #
Multiple myeloma * # * # * #
Leukemia * # * # * #
Acute lymphocytic * # * # * #
Chronic lymphocytic * # * # * #
Acute myeloid * # * # * #
Chronic myeloid * # * # * #
Other leukemias * # * # * #
Other, ill-defined and unknown sites 7 20.6** * # * #

1 Per 100,000; Age-adjusted, 1970 U.S. Standard Million. Excludes in situ cancers except bladder, and also excludes basal and squamous cell carcinomas of the skin.
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than twenty cases are unstable.
# Rate cannot be calculated.
_______________________________________________________________

Source:  Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, January 2001

Table I Index
Table of Contents